Fig. 1From: Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b studyStudy flowchart. mITT: modified intent-to-treat; QoL = quality of lifeBack to article page